Kiadis Pharma Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- Kiadis Pharma's estimated annual revenue is currently $30.7M per year.
- Kiadis Pharma's estimated revenue per employee is $155,000
- Kiadis Pharma has 198 Employees.
- Kiadis Pharma grew their employee count by 77% last year.
- Kiadis Pharma currently has 7 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|LSNE Contract M...||$50.7M||327||13%||N/A|
What Is Kiadis Pharma?
Kiadis Pharma is a clinical stage biopharmaceutical company focused on research, development and future commercialisation of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. Kiadis Pharma is committed to developing innovative and potentially life'saving therapies for patients with late-stage blood cancers and patients with inherited blood disorders, who are in need of a transplant, an area of significant unmet medical need.keywords:N/A
Number of Employees
Employee Growth %
|Maryann Cimino||Manager, Investor Relations & Corporate Affairs|
|Scott Holmes||Chief Financial Officer|
|Robert Igarashi||Vice President Of Discovery And Pre-clinical Development|
|Marcia Blackmoore||Associate Director|
|Andrew Sandler||Chief Medical Officer|
|Amy Sullivan||Svp, Corporate Affairs|
Kiadis Pharma News
Arthur Lahr, CEO of Kiadis Pharma, commented: “In the first six months of 2019, through the acquisition of Cytosen, we have transformed Kiadis ...
Company announces Notice of Results for the six months ended June 30, 2019. Amsterdam, The Netherlands, August 19, 2019 – Kiadis ...
Kiadis Pharma N.V. (OTC:KIADF) Q2 2019 Earnings Conference Call September 10, 2019 9:00 AM ET. Company Participants. Amy Sullivan ...